Bieniossek C., Schütz P., Bumann M., Limacher A., Uson I. and Baumann U. 2006 The crystal structure of the carboxy-terminal domain of human translation initiation factor eIF5. J. Mol. Biol. 360, 457–465.

Article  CAS  PubMed  Google Scholar 

Bugiani M., Boor I., Powers J. M., Scheper G. C. and van der Knaap M. S. 2010 Leukoencephalopathy with vanishing white matter: a review. J. Neuropathol. Exp. Neurol. 69, 987–996.

Article  PubMed  Google Scholar 

Damon-Perriere N., Menegon P., Olivier A., Boespflug-Tanguy O., Niel F., Creveaux I., Dousset V., Brochet B. and Goizet C. 2008 Intra-familial phenotypic heterogeneity in adult onset vanishing white matter disease. Clini. Neurol. Neurosurg. 110, 1068–1071.

Article  Google Scholar 

Elsby R., Heiber J. F., Reid P., Kimball S. R., Pavitt G. D. and Barber G. N. 2011 The alpha subunit of eukaryotic initiation factor 2B (eIF2B) is required for eIF2-mediated translational suppression of vesicular stomatitis virus. J. Virol. 85, 9716–9725.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fogli A., Rodriguez D., Eymard-Pierre E., Bouhour F., Labauge P., Meaney B. F. et al. 2003 Ovarian failure related to eukaryotic initiation factor 2B mutations. Am. J. Hum. Genet. 72, 1544–1550.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fogli A., Schiffmann R., Bertini E., Ughetto S., Combes P., Eymard-Pierre E. et al. 2004 The effect of genotype on the natural history of eIF2B-related leukodystrophies. Neurology 62, 1509–1517.

Article  CAS  PubMed  Google Scholar 

Gomez E. and Pavitt G. D. 2000 Identification of domains and residues within the ɛ subunit of eukaryotic translation initiation factor 2B (eIF2Bɛ) required for guanine nucleotide exchange reveals a novel activation function promoted by eIF2B complex formation. Mol. Cell. Biol. 20, 3965–3976.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hamilton E. M., van der Lei H. D., Vermeulen G., Gerver J. A., Lourenço C. M., Naidu S. et al. 2018 Natural history of vanishing white matter. Ann. Neurol. 84, 274–288.

Article  PubMed  PubMed Central  Google Scholar 

Ibitoye R., Renowden S., Faulkner H., Scolding N. and Rice C. 2016 Ovarioleukodystrophy due to EIF2B5 mutations. Pract. Neurol. 16, 496–499.

Article  CAS  PubMed  Google Scholar 

Imam I., Brown J., Lee P., Thomas P. K. and Manji H. 2011 Ovarioleukodystrophy: report of a case with the c.338G>A (p.Arg113His) mutation on exon 3 and the c.896G>A (p.Arg299His) mutation on exon 7 of the EIF2B5 gene. BMJ Case Rep. 2011, bcr1120103552.

Article  PubMed  PubMed Central  Google Scholar 

Labauge P., Horzinski L., Ayrignac X., Blanc P., Vukusic S., Rodriguez D. et al. 2009 Natural history of adult-onset eIF2B-related disorders: a multi-centric survey of 16 cases. Brain 132, 2161–2169.

Article  PubMed  Google Scholar 

Leegwater P. A., Vermeulen G., Könst A. A., Naidu S., Mulders J., Visser A. et al. 2001 Subunits of the translation initiation factor eIF2B are mutant in leukoencephalopathy with vanishing white matter. Nat. Genet. 29, 383–388.

Article  CAS  PubMed  Google Scholar 

Peter L., Niel F., Catenoix H., Jung J., Demarqua G., Petiot P., Rudigoz R., Boespflug-Tanguy O., Ryvlin P. and Mauguiere F. 2008 Acute neurological deterioration in ovarioleukodystrophy related to EIF2B mutations: pregnancy with oocyte donation is a potentially precipitating factor. Eur. J. Neurol. 15, 94–97.

CAS  PubMed  Google Scholar 

Prass K., Brück W., Schröder N. W., Bender A., Prass M., Wolf T. et al. 2001 Adult-onset leukoencephalopathy with vanishing white matter presenting with dementia. Ann. Neurol. 50, 665–668.

Article  CAS  PubMed  Google Scholar 

Pronk J. C., van Kollenburg B., Scheper G. C. and van der Knaap M. S. 2006 Vanishing white matter disease: a review with focus on its genetics. Ment. Retard. Dev. Disabil. Res. Rev. 12, 123–128.

Article  PubMed  Google Scholar 

Rodrigues C. H., Pires D. E. and Ascher D. B. 2018 DynaMut: predicting the impact of mutations on protein conformation, flexibility and stability. Nucleic Acids Res. 46, W350–W355.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Saberi M., Golchehre Z., Karamzade A., Entezam M., Eshaghkhani Y., Alavinejad E. et al. 2019 CRB1-related leber congenital amaurosis: reporting novel pathogenic variants and a brief review on mutations spectrum. Iran. Biomed. J. 23, 362.

Article  PubMed  PubMed Central  Google Scholar 

Scheper G. C., Van Der Knaap M. S. and Proud C. G. 2007 Translation matters: protein synthesis defects in inherited disease. Nat. Rev. Genet. 8, 711–723.

Article  CAS  PubMed  Google Scholar 

Slynko I., Nguyen S., Hamilton E. M., Wisse L. E., de Esch I. J., de Graaf C. et al. 2021 Vanishing white matter: Eukaryotic initiation factor 2B model and the impact of missense mutations. Mol. Genet. Genom. Med. 9, e1593.

CAS  Google Scholar 

Van Der Knaap M. S., Van Berkel C. G., Herms J., Van Coster R., Baethmann M., Naidu S. et al. 2003 eIF2B-related disorders: antenatal onset and involvement of multiple organs. Am. J. Hum. Genet. 73, 1199–1207.

Article  PubMed  PubMed Central  Google Scholar 

Van Der Knaap M. S., Leegwater P., Van Berkel C., Brenner C., Storey E., Di Rocco M. et al. 2004 Arg113His mutation in eIF2Bε as cause of leukoencephalopathy in adults. Neurology 62, 1598–1600.

Article  PubMed  Google Scholar 

van der Knaap M. S., Pronk J. C. and Scheper G. C. 2006 Vanishing white matter disease. Lancet Neurol. 5, 413–423.

Article  PubMed  Google Scholar 

Van der Lei H., van Berkel C., van Wieringen W., Brenner C., Feigenbaum A., Mercimek-Mahmutoglu S. et al. 2010 Genotype–phenotype correlation in vanishing white matter disease. Neurology 75, 1555–1559.

Article  PubMed  Google Scholar